5 Best Stocks to Buy for the Next 10 Years

2. Exicure, Inc. (NASDAQ:XCUR)

Trailing P/E Ratio: 0.23

Exicure, Inc. (NASDAQ:XCUR) is an American biotechnology company developing pain and cancer treatments. It is part of the highly speculative biotechnology sector that often sees firms either post explosive growth or go out of business, and Exicure, Inc. (NASDAQ:XCUR)’s average revenue growth rate is 24%.

During 2023’s September quarter, three hedge funds out of the 910 polled by Insider Monkey had invested in the company. Clint Carlson’s Carlson Capital was the largest Exicure, Inc. (NASDAQ:XCUR) stakeholder courtesy of its $82,080 stake.

Follow Exicure Inc. (NASDAQ:XCUR)